One injection of nirsevimab reliably protects newborns against the development of RSV-associated lower respiratory tract infections.
Infections
Posted inCOVID-19, Infections, New Drugs, Regulatory
Pfizer and Moderna Release Booster Vaccines to Protect Against Omicron
Updated bivalent mRNA vaccines Comirnaty and Spikevax target Omicron subvariants BA.4 and BA.5.
Posted inCOVID-19, Infections, Research
Omicron Treatment: Most Effective Drugs
Efficacy of antivirals and monoclonal antibodies for outpatient treatment of COVID-19 infection with the Omicron variant of SARS-CoV-2 coronavirus.
Posted inCOVID-19, Infections, Pharma & Biotech
Moderna Declared War on Pfizer
Billions of dollars made from vaccines are at stake.
Posted inCOVID-19, Infections, Regulatory
Paxlovid for COVID-19 Treatment. All Details
Paxlovid: treatment efficacy, “Paxlovid mouth”, COVID-19 rebound, management of Omicron variant, treatment resistance, generics, mechanism of action, price.
Posted inClinical Trials, COVID-19, Infections
BCG Vaccination: Almost Absolute Protection Against COVID-19
BCG is a universal vaccine that protects against SARS-CoV-2 coronavirus of any variant.
Posted inCOVID-19, Infections, New Drugs, Regulatory
First Omicron Vaccine Appears
Spikevax bivalent Original / Omicron (elasomeran + imelasomeran; mRNA-1273.214) by Moderna is the world’s first vaccine to protect against the Omicron variant of the SARS-CoV-2 coronavirus.